AXIN1 and cancer: Of note, it has been reported that the STK11 mutation was involved in metabolic reprogramming of cancer cells [19,20], and metformin modulates metabolism predominantly through AXIN1-dependent activation of AMP-activated protein kinase (AMPK) [21,22].